News
SHLT
5.10
-5.20%
-0.28
SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
SHL Telemedicine Ltd. Has officially launched it’s SmartHeart® membership program in the US. The SmartHeart membership is a private pay program designed to revolutionize home-based access to cardiac care. The membership includes the innovative, portable 12-lead ECG device and on-demand telehealth visits.
Barchart · 3d ago
Weekly Report: what happened at SHLT last week (0506-0510)?
Weekly Report · 6d ago
Weekly Report: what happened at SHLT last week (0429-0503)?
Weekly Report · 05/06 10:38
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. GeneDx Hldgs shares rose 43.54% as the company's market cap rose to $411.3 million. Tenet Healthcare (NYSE:THC) stock increased by 9.93% after their Q1 earnings report came out yesterday.
Benzinga · 04/30 12:06
Weekly Report: what happened at SHLT last week (0422-0426)?
Weekly Report · 04/29 10:43
Weekly Report: what happened at SHLT last week (0415-0419)?
Weekly Report · 04/22 10:36
SHL Telemedicine reports FY results
Seeking Alpha · 04/17 09:18
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
SHL Telemedicine Ltd. Announced its results for the full-year 2023. Total revenues rose to $57.1m. Revenues from the company's operation in Israel increased by 2.3%. In the US, the company launched direct-to-consumer sales of the SmartHeart® ECG platform.
Barchart · 04/17 04:00
Weekly Report: what happened at SHLT last week (0408-0412)?
Weekly Report · 04/15 10:29
Imperial College Study Reveals SHL Telemedicine's SmartHeart® Drastically Cuts Hospital Readmissions By 76% And Lowers Emergency Visits By 41%
Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits for post-MI heart attack patients at home. The results of the Imperial College London TELE-ACS trial underscore SmartHeart's pivotal role in remote cardiac care.
Benzinga · 04/11 07:30
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
SHL Telemedicine Ltd. Announces the results of the Imperial College London TELE-ACS Trial. The randomized clinical trial showcased how SHL’s SmartHeart® 12-lead ECG technology can significantly reduce hospital readmissions and ED visits for post-MI (heart attack) patients at home. The study found a 76% reduction in the likelihood of hospital readmission within six months for patients using SHL's SmartHeart.
Barchart · 04/11 01:10
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Longeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during Monday's pre-market session. PetVivo Hldgs stock increased by 17.09% and SHL Telemedicine stock moved up by 13.26%. Losers include Supernus Pharmaceuticals and G1 Therapeutics.
Benzinga · 04/08 12:09
Weekly Report: what happened at SHLT last week (0401-0405)?
Weekly Report · 04/08 10:32
SHL's SmartHeart ECG Technology Showcases Potential in US Army's Largest Field Experiment
SHL's SmartHeart® portable 12-lead ECG technology participated in Project Convergence – Capstone 4 in the Mojave Desert. The technology was used in a multi-day military medical experiment in the rugged desert conditions. The SmartHeart technology is designed to revolutionize cardiovascular assessment in non-traditional settings. SmartHeart's inclusion in this prestigious experiment underscores the growing recognition of the technology.
Benzinga · 04/08 07:04
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
SHL Telemedicine Ltd. Participated in Project Convergence – Capstone 4 in the Mojave Desert. The company's SmartHeart® portable 12-lead ECG technology showcased its unparalleled capabilities. The SmartHeart was used in a multi-day military medical experiment in the rugged desert. SmartHeart is designed to revolutionize urgent cardiovascular assessment in non-traditional settings.
Barchart · 04/08 01:30
SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
SHL Telemedicine Ltd. Will publish its results for 2023 on Wednesday, April 17, 2024 at 7 am CET. The conference call for investors, journalists, and analysts will be held in English. The company is a leading provider and developer of advanced personal telemedicina solutions.
Barchart · 04/05 01:30
Weekly Report: what happened at SHLT last week (0325-0329)?
Weekly Report · 04/01 10:32
Weekly Report: what happened at SHLT last week (0318-0322)?
Weekly Report · 03/25 10:34
Weekly Report: what happened at SHLT last week (0311-0315)?
Weekly Report · 03/18 10:32
Litchfield Hills Initiates Coverage On SHL Telemedicine with Buy Rating, Announces Price Target of $11
Benzinga · 03/14 11:51
More
Webull provides a variety of real-time SHLT stock news. You can receive the latest news about SHL Telemed through multiple platforms. This information may help you make smarter investment decisions.
About SHLT
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.